Viewing Study NCT03387332

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:23 PM
Ignite Modification Date: 2026-02-01 @ 9:32 PM
Study NCT ID: NCT03387332
Status: TERMINATED
Last Update Posted: 2021-08-27
First Post: 2017-12-13
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: APG-1252 in Patients With SCLC or Advanced Solid Tumors
Sponsor: Ascentage Pharma Group Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Small Cell Lung Cancer and Other Solid Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Bcl-2/Bcl-xL dual inhibitor View